The European Commission president has said the European Medicines Agency could begin authorising the marketing of two leading coronavirus vaccines before the end of the year.
Speaking last night following a video conference of EU leaders, Ursula von der Leyen said that if ongoing testing is successful, both the Pfizer/BioNTech and the Moderna vaccines could be authorised in the second half of December.
She urged member states to coordinate plans on which population groups would be prioritised to receive the vaccines when they become available.
There have been two big vaccine breakthroughs so far: one from Pfizer/BioNTech and another from Moderna. They are both very different vaccines and have different strengths and drawbacks, but before